A Novel Method to Differentiate Tonsil-Derived Mesenchymal Stem Cells In Vitro into Estrogen-Secreting Cells
- 28 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Tissue Engineering and Regenerative Medicine
- Vol. 18 (2), 253-264
- https://doi.org/10.1007/s13770-020-00307-y
Abstract
BACKGROUND: The advantages of tonsil-derived mesenchymal stem cells (TMSCs) over other mesenchymal stem cells (MSCs) include higher proliferation rates, various differentiation potentials, efficient immune-modulating capacity, and ease of obtainment. Specifically, TMSCs have been shown to differentiate into the endodermal lineage. Estrogen deficiency is a major cause of postmenopausal osteoporosis and is associated with higher incidences of ischemic heart disease and cerebrovascular attacks during the postmenopausal period. Therefore, stem cell-derived, estrogen-secreting cells might be used for estrogen deficiency. METHODS: Here, we developed a novel method that utilizes retinoic acid, insulin-like growth factor-1, basic fibroblast growth factor, and dexamethasone to evaluate the differentiating potential of TMSCs into estrogen-secreting cells. The efficacy of the novel differentiating method for generation of estrogen-secreting cells was also evaluated with bone marrow- and adipose tissue-derived MSCs. RESULTS: Incubating TMSCs in differentiating media induced the gene expression of cytochrome P450 19A1 (CYP19A1), which plays a key role in estrogen biosynthesis, and increased 17β-estradiol secretion upon testosterone addition. Furthermore, CYP11A1, CYP17A1, and 3β-hydroxysteroid dehydrogenase type-1 gene expression levels were significantly increased in TMSCs. In bone marrow-derived and adipose tissue-derived MSCs, this differentiation method also induced the gene expression of CYP19A1, but not CYP17A1, suggesting TMSCs are a superior source for estrogen secretion. CONCLUSION: These results imply that TMSCs can differentiate into functional estrogen-secreting cells, thus providing a novel, alternative cell therapy for estrogen deficiency.Keywords
Funding Information
- Ministry of Education (NRF-2017R1E1A1A01073021)
- Ministry of Health and Welfare (HI18C2392)
This publication has 39 references indexed in Scilit:
- Aromatase Variants Modify Risk for Alzheimer's Disease in a Multiethnic Female CohortDementia and Geriatric Cognitive Disorders, 2013
- Identification of an estrogen receptor alpha non-covalent ubiquitin binding surface: role in 17beta-estradiol-induced transcriptional activityJournal of Cell Science, 2013
- Postmenopausal hormonal therapy: Current statusIndian Journal of Endocrinology and Metabolism, 2013
- Estradiol Synthesis and Release in Cultured Female Rat Bone Marrow Stem CellsBioMed Research International, 2012
- Tissue physiology and pathology of aromataseSteroids, 2012
- Estrogen and androgen receptors: regulators of fuel homeostasis and emerging targets for diabetes and obesityTrends in Endocrinology & Metabolism, 2011
- A novel promoter controls Cyp19a1 gene expression in mouse adipose tissueReproductive Biology and Endocrinology, 2009
- Variants in Estrogen Biosynthesis Genes, Sex Steroid Hormone Levels, and Endometrial Cancer: A HuGE ReviewAmerican Journal of Epidemiology, 2006
- Estrogen deficiency and bone loss: an inflammatory taleJCI Insight, 2006
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001